← Open Payments lookup

DANIELLE GLICK: Open Payments

NPI 1104230531 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,516 in 124 payments from 22 companies in 2025. Trend: 2023 $1,710 · 2024 $2,562 · 2025 $2,516

Food & beverage: $2,516
CompanyPaymentsAmount
ABBVIE INC.33$577
Janssen Biotech, Inc.12$245
Ardelyx, Inc.16$223
Madrigal Pharmaceuticals11$203
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$159
GENZYME CORPORATION4$142
Aimmune Therapeutics, Inc.5$132
Regeneron Pharmaceuticals, Inc.1$124
Takeda Pharmaceuticals U.S.A., Inc.5$120
Phathom Pharmaceuticals, Inc.7$98

Products named: DUPIXENT, RINVOQ, TREMFYA, IBSRELA, REZDIFFRA, XIFAXAN, CREON, ZENPEP.

Industry payments across IN — which companies pay providers there.